Endometrial Neoplasms Clinical Trial
Official title:
Randomised, Controlled, Pilot Clinical Trial to Assess the Feasibility of a Healthy Eating and Physical Activity Program in Endometrial Cancer Survivors
Endometrial cancer is the most common gynaecological cancer in developed countries with more
than 75% of the patients surviving for at least five years. However, most endometrial cancer
survivors are overweight and obese and do not meet the current nutrition and physical
activity recommendations. This can lower their quality of life and increase their risk for
chronic diseases. Behaviour change interventions can help them feel better about themselves
and improve their quality of life. Applying them shortly after treatment seems ideal as
cancer survivors feel motivated to make changes about their lifestyle at this time point.
This study is to see if the investigators can design a project to measure how well a
psycho-educational healthy eating and physical activity programme tailored to the survivors'
needs works. Sixty-four endometrial cancer survivors diagnosed during the previous three
years, and are all clear will be put by chance into one of two groups. One will receive the
program. The other will receive usual care until the end of the trial and, then, a discussion
and a self-help guide about eating well and being active following cancer treatment. This
will help us to see if the programme makes a difference compared with usual care. The results
will inform a larger study to test if a lifestyle program can improve the quality of life of
uterine cancer survivors compared with usual care. The investigators will change the
programme materials in response to the investigators' findings, making them available to
services. The results will inform practice and research.
Low physical activity, poor diet and obesity are risk factors for the development of
endometrial cancer. A growing body of evidence suggests that they may be linked with quality
of life after cancer treatment. However, only about 1% of endometrial cancer survivors seem
to meet the current fruit and vegetable, physical activity, and non-smoking recommendations;
while 57% meets only the non-smoking recommendations, and 22% meet none of the
recommendations,
These behaviours exist despite cancer diagnosis being perceived as a "teachable moment".
Capitalising the "teachable moment" of cancer, behaviour change interventions in high-risk
populations might be more effective than those targeting the general population.
Theory-based behaviour change interventions suggest that improving diet and physical activity
is safe, acceptable, and feasible and can help cancer survivors improve their quality of
life. In contrast, there are only limited studies to support these data in the United Kingdom
to allow generalisability of these results. However, the majority of these interventions were
long-term and resource intensive which may render them inappropriate for wide dissemination.
Therefore, feasible and effective interventions are needed to promote implementation of the
nutrition and physical activity guidelines.
The intervention is based on the Shape-Up eight-week weight management programme. This
programme is based on "Social Cognitive Theory" and "Control Theory". A version of this
program has been favourably evaluated in terms of acceptability, physical, and psychological
outcomes. We have tailored this programme (Shape-Up following cancer treatment) to help
endometrial cancer survivors improve their diet, and activity pattern. The focus of the
programme lies on self-control, self-efficacy, and relapse prevention in terms of healthy
eating and physical activity. Behavioural techniques will include self-monitoring of
behaviour with the use of food and physical activity diaries, behavioural goal setting,
action planning, graded tasks, problem solving, self-reward, and review of behavioural goals.
It will also provide information about health consequences and emotional consequences, pros
and cons, behavioural practice, habit formation, reducing exposure to cues for the behaviour,
behaviour substitution, distraction, social support (unspecified), demonstration of behaviour
(for resistance exercises), instructions on how to perform the behaviour (for resistance
exercises), and reframing.
The DEUS pilot trial is an eight-week, two-arm, individually randomised, controlled pilot
trial comparing the use of the "Shape-Up following cancer treatment" programme to usual care.
According to Medical Research Council guidance for complex interventions, this is a Phase 2
feasibility study. Randomisation will be performed with minimisation using a 1:1 allocation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT06409039 -
POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation
|
||
Completed |
NCT02865889 -
Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications
|
N/A | |
Completed |
NCT00377520 -
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
|
Phase 2 | |
Recruiting |
NCT05007106 -
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
|
Phase 2 | |
Recruiting |
NCT05001282 -
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05682950 -
Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
|
Phase 2 | |
Not yet recruiting |
NCT05974995 -
Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer
|
N/A | |
Recruiting |
NCT03291106 -
Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer
|
||
Recruiting |
NCT03291275 -
Survival Outcomes of Uterine Malignancies in Chinese Population
|
N/A | |
Completed |
NCT00341458 -
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics
|
||
Terminated |
NCT05067972 -
A Study of PF-07260437 in Advanced or Metastatic Solid Tumors
|
Phase 1 | |
Recruiting |
NCT05795244 -
Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC)
|
Phase 2 | |
Recruiting |
NCT05770102 -
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04865289 -
Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study
|
Phase 3 | |
Completed |
NCT03270995 -
Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study
|
N/A | |
Terminated |
NCT01969396 -
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
|
N/A | |
Completed |
NCT01460979 -
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
|
Phase 2 | |
Active, not recruiting |
NCT05869123 -
Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
||
Active, not recruiting |
NCT05588076 -
Endometrial Lesions Predictions
|